B. Ledergerber

Discipline

Psychologie (2) Sociologie (1) Economies et finances (1) Anthropologie biologique (1)

Type de document

Articles (47)

Co-auteur

Date

Source

Mot-clé

cohorte (41) Swiss (36) Treatment (35) Methods (34) Methods (34) thérapie (33) Therapeutics (33) Human beings (29) Patients (28) Patients (28) virus (25) Immunodeficiency (25) Ci (Chinese poetry) (20) Risk (20) Older people (20) risque (19) adulte (19) adulte (19) Confidence (18) Models (17) Population (16) Population (16) association (15) art (15) Art (15) Art (15) Social groups (15) Art (15) Use (15) art (15)

Documents écrit par B. Ledergerber (47) | parle de B. Ledergerber (0)

Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.
J. Damas et al. (1 déc. 2021)
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
T. Turk et al. (12 sept. 2017)
Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study.
C. Bayard et al. (2017)
CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART.
R. Sauter et al.
Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study.
T. Junier et al. (2016)
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013
G. Wandeler et al. (2015)
Increases in condomless sex in the Swiss HIV Cohort Study.
R.D. Kouyos et al. (2015)
Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS).
A. Anagnostopoulos et al. (2015)
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
D.L. Braun et al. (2015)
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
W.L. Yang et al. (2015)
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.
D. Carballo et al. (2015)
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
H. Kovari et al. (2015)
Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population.
B. Hasse et al. (2015)
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.
W.L. Yang et al. (2015)
Reasons for late presentation to HIV care in Switzerland.
A. Hachfeld et al. (2015)
Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide.
R.D. Kouyos et al. (2014)
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
B. Hasse et al. (2014)
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study.
S.M. Drescher et al. (2014)
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
M. Arab-Alameddine et al. (2014)
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV.
R.D. Kouyos et al. (2014)
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
A.U. Scherrer et al. (2012)
Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens.
A.U. Scherrer et al. (2012)
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
V. von Wyl et al. (2012)
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.
B. Hasse et al. (2011)
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
R. Lubomirov et al. (2011)

next